Biotech Startups

Niacet produces anhydrous hydrogen chloride and hydrochloric acid at ultra-high purity grades for use in pharmaceutical, chemical, and electronics industries. The company specializes in electronics-grade products at 99.999% purity and technical-grade variants, along with hydrochloric acid solutions at various concentrations.

1 investor

Nikon is a manufacturer of imaging products including cameras, lenses, and optical equipment for professional and consumer markets.

1 investor

Nilo Therapeutics develops immunomodulation therapies that target brain-body neural circuits controlling systemic inflammation, aiming to treat autoimmune and inflammatory diseases. Its approach is focused on restoring immune homeostasis in conditions with large unmet medical need.

1 investor

1 investor

A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas. The page content appears to redirect to AbbVie, and provides limited specific information about Nimble Therapeutics itself.

1 investor

Nirvana Sciences develops dyes, probes, and contrast agents for life science applications, including organic dyes with narrow emission profiles and a library of over 700 chlorin and bacteriochlorin designs. Its products target life science research and imaging uses.

1 investor

1 investor

Nivagen provides drug product development services, guiding pharmaceutical companies through the full lifecycle from concept to commercialization, including traditional NDAs, 505(b)(2)s, and complex generics. The company serves pharmaceutical and biotech firms seeking to bring innovative drug products to market with intellectual property protection and accelerated timelines.

1 investor

NKILT Therapeutics is a cell therapy biotech developing engineered immune cells, starting with natural killer (NK) cells, to target leukemias and solid tumors. It uses a proprietary Chimeric ILT-Receptor (CIR) binding technology to create off-the-shelf, allogeneic cancer treatments targeting the HLA-G immune checkpoint molecule.

1 investor

N-Kure focuses on cell therapies, though the page content provided does not include sufficient detail about specific products or customer markets to formulate a complete description.

1 investor

Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.

1 investor

Noble Biomaterials engineers proprietary antimicrobial and conductive technology platforms for mission-critical applications in consumer, aerospace & defense, and healthcare markets. Its Ionic+ and Circuitex technologies enable odor elimination, infection prevention, EMI shielding, and smart fabric functionality.

1 investor

NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.

1 investor

Nopalm Ingredients uses biomass fermentation with a non-GMO yeast strain to upcycle agri-food side streams (such as potato peels and rejected vegetables) into oils and fats that serve as palm oil alternatives. Its REVÓLEO platform supplies semi-solid fats for food applications and soft butters for cosmetics and personal care manufacturers.

1 investor

Norachem applies computational and mathematical methods to drug design, drawing on expertise in science, engineering, and business development. The company operates in the computational drug discovery space.

1 investor

Nordic Bio Food develops plant-based food products made from legumes and enzymes instead of additives, aiming for high-protein, additive-free formulations. It works with customers in the food and meat processing industry to create recipes suited to existing industrial equipment and regional preferences.

1 investor

Nordic Biomarker manufactures advanced reagents, calibrators, and controls for coagulation and clinical chemistry analyzers used in diagnostic laboratories. The company supplies products to healthcare providers both through OEM partnerships and under its own Medirox brand.

1 investor

Nornir Labs develops a platform-agnostic ultrafast phenotypic antibiotic susceptibility testing (AST) technology.

1 investor

Northern Light Microscopy develops advanced imaging technology for life-science laboratories and companies to support bioscience discovery and research. The company specializes in microscopy solutions with expertise in advanced microscopy and optical engineering.

1 investor

NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17, an intranasal antiviral designed to prevent respiratory virus infections by blocking viral entry at the nasal epithelium. The company targets broad protection against multiple respiratory viruses through a strain-independent mechanism.

1 investor

NorthStar Medical Technologies develops and commercializes innovative nuclear medicine products and technologies for the pharmaceutical and life sciences industries.

1 investor

Northwest Biotherapeutics is a clinical-stage biotechnology company developing personalized cancer vaccines, marketed under the DCVax platform, that use activated dendritic cells to treat a range of solid tumor cancers. Its product lines include DCVax-L, DCVax-Direct, and DCVax-Prostate.

1 investor

1 investor

Notify develops pharmaceutical treatments for women with diminished ovarian reserves by targeting dormant follicle activation through NRF2 pathway modulation. The company's approach addresses early-stage egg development independent of hormonal processes, offering a potential solution for women who do not benefit from existing fertility treatments.

1 investor